SCYNEXIS INC
For the period ended Dec 31, 2025. Filed Mar 4, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 4, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Power of Attorney (see Signature page)
POWER OFATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints David Angulo, M.D. and Scott Sukenick, as his or her true and lawful attorney-in-fact and agent, with full power of substitution for him or her, and in his or her name in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, and any of them or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ David Angulo, M.D. | Chief Executive Officer | March 3, 2026 |
| David Angulo, M.D. | (Principal Executive Officer) | |
| /s/ Ivor Macleod | Chief Financial Officer | March 3, 2026 |
| Ivor Macleod | (Principal Financial and Accounting Officer) | |
| /s/ Guy Macdonald | Director | March 2, 2026 |
| Guy Macdonald | ||
| /s/ David Hastings | Director | March 2, 2026 |
| David Hastings | ||
| /s/ Steven C. Gilman, Ph.D. | Director | March 2, 2026 |
| Steven C. Gilman, Ph.D. | ||
| /s/ Ann F. Hanham, Ph.D. | Director | March 2, 2026 |
| Ann F. Hanham, Ph.D. | ||
| /s/ Armando Anido | Director | March 2, 2026 |
| Armando Anido | ||
| /s/ Brian Philippe Tinmouth | Director | March 2, 2026 |
| Brian Philippe Tinmouth | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.